Home   Contact Palatin   Site Map  

Investor/Media Center

Press Releases

 
2006 2007 2008 2009 all
 
 

 
Displaying releases: 1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-100


  May-04-2006 Palatin Technologies and King Pharmaceuticals Complete Enrollment In Two Phase IIB Clinical Trials Evaluating Bremelanotide In Patients With Erectile Dysfunction
  May-01-2006 Palatin Technologies to Report Third Quarter, Fiscal Year 2006 Financial Results; Conference Call and Webcast on May 9th
  Apr-17-2006 Palatin Technologies, Inc. Completes $27 Million Offering
  Apr-12-2006 Palatin Technologies, Inc. to Raise $27 Million in Offering
  Mar-09-2006 Bremelanotide Clinical Trial Results Presented At The International Society For The Study Of Women's Sexual Health 2006 Annual Meeting
  Feb-09-2006 Palatin Technologies, Inc. Reports Fiscal Year 2006 Second Quarter Results; Teleconference And Webcast Being Held Today At 10:00 A.M. Est
  Feb-08-2006 USAN and WHO Approve Generic Name Bremelanotide For PT-141, First In A New Class Of Experimental Treatments For Sexual Dysfunction
  Feb-07-2006 Palatin Technologies and King Pharmaceuticals Initiate Phase IIB Clinical Trial Evaluating PT-141 In Patients Suffering From Female Sexual Arousal Disorder
  Feb-03-2006 Palatin Technologies to Report Second Quarter, Fiscal Year 2006 Financial Results; Teleconference and Webcast on February 9th
  Jan-05-2006 Palatin Technologies to Present at the JPMorgan 24th Annual Healthcare Conference